Cargando…
Silencing of miR-193a-5p increases the chemosensitivity of prostate cancer cells to docetaxel
BACKGROUND: Docetaxel-based chemotherapy failure in advanced prostate carcinoma has partly been attributed to the resistance of prostate cancer (PC) cells to docetaxel-induced apoptosis. Hence, there is an urgent need to identify mechanisms of docetaxel chemoresistance and to develop new combination...
Autores principales: | Yang, Zhan, Chen, Jin-Suo, Wen, Jin-Kun, Gao, Hai-Tao, Zheng, Bin, Qu, Chang-Bao, Liu, Kai-Long, Zhang, Man-Li, Gu, Jun-Fei, Li, Jing-Dong, Zhang, Yan-Ping, Li, Wei, Wang, Xiao-Lu, Zhang, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721613/ https://www.ncbi.nlm.nih.gov/pubmed/29216925 http://dx.doi.org/10.1186/s13046-017-0649-3 |
Ejemplares similares
-
Silencing of LINC01963 enhances the chemosensitivity of prostate cancer cells to docetaxel by targeting the miR-216b-5p/TrkB axis
por: Xing, Zengshu, et al.
Publicado: (2022) -
Dysregulation of p53-RBM25-mediated circAMOTL1L biogenesis contributes to prostate cancer progression through the circAMOTL1L-miR-193a-5p-Pcdha pathway
por: Yang, Zhan, et al.
Publicado: (2018) -
miR-193b Increases the Chemosensitivity of Osteosarcoma Cells by Promoting FEN1-Mediated Autophagy
por: Dong, Suwei, et al.
Publicado: (2019) -
Methylation‐associated miR‐193b silencing activates master drivers of aggressive prostate cancer
por: Mazzu, Ying Z., et al.
Publicado: (2019) -
Morin promotes prostate cancer cells chemosensitivity to paclitaxel through miR-155/GATA3 axis
por: Li, Bin, et al.
Publicado: (2017)